| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.082 | 0.05 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.09 | 0.06 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.084 | 0.06 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.075 | 0.08 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.034 | 0.4 |